Higher prevalence of urogenital mycoplasmas in human immunodeficiency virus-positive patients as compared to patients with other sexually transmitted diseases

被引:0
|
作者
Cordova, CMM
Blanchard, A
Cunha, RAF
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut, Lab Imunol Clin, BR-05508900 Sao Paulo, Brazil
[2] Inst Pasteur, Unite Oncol Virale, F-75724 Paris, France
关键词
Mycoplasma genitalium; M; fermentans; penetrans; HIV; STD; nongonococcal urethritis (NGU); PCR;
D O I
10.1002/1098-2825(2000)14:5<246::AID-JCLA8>3.0.CO;2-F
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We determined the prevalence of three emergent urogenital mycoplasma species (M. fermentans, M. penetrans, and M. genitalium) in comparison to the most common species (RI. hominis and U. urealyticum). M. genitalium is probably the third most frequent agent of nongonococcal urethritis (NGU) in men. It has been suggested that M. fermentans and M. penetrans play a role in the development of AIDS. We analysed the urine and the urethral swab samples from 106 HIV-1 infected individuals (HIV group) and 110 HIV-negative patients with NGU (STD group) by using PCR and culture methods. M. genitalium was detected in 0.9% of the urine and in 1.9% of the urethral samples from the HIV group, compared to 9.1% found only in urethral swab samples from the STD group. M. fermentans was detected in 5.7% urethral swabs from the HIV group and in 0.9% from the STD group. M. penetrans was detected in 6.6% urine samples from the HIV group. M. hominis and U. urealyticum showed infection rates of 7.5 and 18.9% in the HIV group, and 0.9 and 13.6% in the STD group. Overall there was a higher prevalence of mycoplasmas in the HIV group than in the STD group, but the significance of these results remains unclear. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 50 条
  • [41] Anal human papillomavirus DNA screening by hybrid capture II™ in human immunodeficiency virus-positive patients with or without anal intercourse
    Drobacheff, C
    Dupont, P
    Mougin, C
    Bourezane, Y
    Challier, B
    Fantoli, M
    Bettinger, D
    Laurent, R
    EUROPEAN JOURNAL OF DERMATOLOGY, 2003, 13 (04) : 367 - 371
  • [42] Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection
    Dezzutti, CS
    Astemborski, J
    Thomas, DL
    Marshall, JH
    Cabrera, T
    Purdy, M
    Vlahov, D
    Garfein, RS
    JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (03) : 210 - 214
  • [43] Willingness of human immunodeficiency virus-positive patients to donate their organs for transplantation in Taiwan: a cross-sectional questionnaire survey
    Lee, Yi-Chieh
    Hung, Chien-Ching
    Cheng, Aristine
    Liu, Wen-Chun
    Wu, Pei-Ying
    Yang, Shang-Ping
    Zhang, Jun-Yu
    Luo, Yu-Zhen
    Chang, Hsi-Yen
    Sun, Hsin-Yun
    Chang, Shan-Chwen
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (06) : 856 - 861
  • [44] Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus-positive and negative patients
    Amaratunge, Bhagya Chathri
    Camuglia, Jayne E.
    Hall, Anthony J.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 38 (01): : 68 - 74
  • [45] Risk Factors for Osteonecrosis of the Femoral Head in Human Immunodeficiency Virus-Positive Patients: A Retrospective Case-Control Study
    Zhao, Rugang
    Ma, Rui
    Zhao, Changsong
    Zhang, Qiang
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2022, 38 (11) : 869 - 874
  • [46] Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus-positive Patients Treated With Protease Inhibitor Monotherapy
    Haddow, Lewis J.
    Godi, Claudia
    Sokolska, Magdalena
    Cardoso, M. Jorge
    Oliver, Ruth
    Winston, Alan
    Stohr, Wolfgang
    Clarke, Amanda
    Chen, Fabian
    Williams, Ian G.
    Johnson, Margaret
    Paton, Nick
    Arenas-Pinto, Alejandro
    Golay, Xavier
    Jager, Hans Rolf
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (06) : 1031 - 1040
  • [47] Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Patients: Incidence and Associated Factors
    Huang, Sung-Hsi
    Huang, Chung-Hao
    Wang, Ning-Chi
    Chen, Tun-Chieh
    Lee, Yuan-Ti
    Lin, Shih-Ping
    Lin, Te-Yu
    Lin, Chi-Ying
    Lee, Yu-Lin
    Lee, Chen-Hsiang
    Chen, Cheng-Pin
    Lin, Kuan-Yin
    Chen, Guan-Jhou
    Liu, Chun-Eng
    Cheng, Shu-Hsing
    Lu, Po-Liang
    Yang, Chia-Jui
    Hung, Chien-Ching
    HEPATOLOGY, 2019, 70 (02) : 465 - 475
  • [48] Oncology treatment outcome in human immunodeficiency virus-positive cancer cervix patients: Where we are and what we achieved?
    Waghmare, Chaitali Manohar
    Bhanu, Arya
    Dwivedi, Shreya
    Pawar, Hemant J.
    Ravichandran, Meenakshi
    Jain, Vandana Shailendra
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 2021 - 1540
  • [49] The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia
    Deressa, Tekalign
    Damtie, Debasu
    Fonseca, Kevin
    Gao, Shan
    Abate, Ebba
    Alemu, Shitaye
    Aleka, Yetemwork
    Swain, Mark G.
    van Marie, Guido
    Coffin, Carla S.
    PLOS ONE, 2017, 12 (12):
  • [50] Prevalence of Sexually Transmitted Infection/Human Immunodeficiency Virus Counseling Services Received by Teen Males, 1995-2002
    Marcell, Arik V.
    Bell, David L.
    Lindberg, Laura D.
    Takruri, Adel
    JOURNAL OF ADOLESCENT HEALTH, 2010, 46 (06) : 553 - 559